Antioxidant oral supplement might help in macular degeneration

NEW YORK (Reuters Health) – An antioxidant oral supplement (Ocuvite, Bausch and Lomb), in particular
its lutein component, may provide benefits in patients with early age-related macular degeneration (AMD), according
to new findings from a secondary analysis of a clinical trial (CARMA).
Source: Modern Medicine: Optometry